Relationship between donepezil and fracture risk in patients with dementia with Lewy bodies.
Shoya MatsumotoMitsutaka YakabeTatsuya HosoiKenji FujimoriJunko TamakiShinichi NakatohShigeyuki IshiiNobukazu OkimotoMasahiro AkishitaMasayuki IkiSumito OgawaPublished in: Geriatrics & gerontology international (2024)
Donepezil administration in Japanese people aged ≥65 years with DLB was significantly associated with a decreased risk of hip fracture. Donepezil may provide new benefits to DLB patients. Geriatr Gerontol Int 2024; ••: ••-••.